Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients
Abstract Background Investigation of novel blood‐circulating agents as potential biomarkers for glioblastoma multiforme (GBM) patients’ diagnosis and monitoring has gained lots of attention, due to limitations of imaging modalities and invasive tissue biopsy procedures. The present study aims to ass...
Main Authors: | Amirhosein Kefayat, Alireza Amouheidari, Fatemeh Ghahremani, Zahra Alirezaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4073 |
Similar Items
-
Prognostic factors in glioblastoma multiforme
by: Leonardo Welling, et al.
Published: (2010-12-01) -
Retrospective Analysis of Prognostic Factors in Adult Glioblastoma Multiforme: A Single Institution Experience
by: Mohamed Abd El Moumen, et al.
Published: (2019-06-01) -
Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
by: Hou AW, et al.
Published: (2016-01-01) -
Biomarkers of Glioblastoma Multiforme
by: Guru Dutta Satyarthee, et al.
Published: (2018-09-01) -
A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy
by: Rongchuan Zhao, et al.
Published: (2021-08-01)